We found that mTOR can directly regulate various inflammatory factors, such as IL-6, IL-12, IL-1, and other members of the IL family, TNF-α, NF-κB, and JNK, which directly affect the pathogenesis of NAFLD by blocking disease development. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.